Home LiteratureArticle Details
PMID: 308698 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Tumor-promoting phorbol esters inhibit binding of epidermal growth factor to cellular receptors.

Science (New York, N.Y.) ·Vol. 202 ·No. 4365 ·1978-10-20 ·Pages 313-5

Lee LS, Weinstein IB

Abstract

Tumor-promoting phorbol esters and related plant macrocyclic diterpenes inhibit the binding of epidermal growth factor to its receptors on HeLa cells. This effect shows marked structural specificity and correlates with other biological effects of these compounds on mouse skin and in cell culture systems. The active compounds inhibited binding of 125I-labeled epidermal growth factor with a 50 per-cent effective dose in the range of 10(-8) to 10(-9) M. Inhibition appears to be due to a decrease in the number of available epidermal growth factor receptors rather than a change in receptor affinity. These results suggest that certain biologic effects of tumor promoters may result from alterations in the function of cell surface receptors involved in growth regulation.

MeSH Terms
Binding, Competitive Cell Membrane/metabolism Epidermal Growth Factor/metabolism HeLa Cells Kinetics Peptides/metabolism Phorbol Esters/metabolism,pharmacology Phorbols/metabolism Receptors, Drug/drug effects,metabolism Tetradecanoylphorbol Acetate/metabolism
Chemicals
Peptides Phorbol Esters Phorbols Receptors, Drug Epidermal Growth Factor Tetradecanoylphorbol Acetate
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Lee L S
Weinstein I B
Article Info
Journal
Science (New York, N.Y.)
Abbr.
Science
ISSN
0036-8075
Published
1978-10-20
Pages
313-5
Language
English
Region
United States
NLM ID
0404511
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]